Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer

Author(s):
Wit, D. de; Schneider, T.C.; Moes, D.J.A.R. (0000-0003-3219-253X); Roozen, C.F.M.; Hartigh, J. den; Gelderblom, H.; Guchelaar, H.J. (0000-0002-7085-1383); Hoeven, J.J. van der; Links, T.P.; Kapiteijn, E.; Erp, N.P. van
Published
2016
Publication type
Article / Letter to editor

Abstract

NCT01118065.

EverolimusExposure-toxicityPopulation pharmacokineticsPharmacogeneticsIndividualized dosing
Date issued
2016-07-01
Language
English
Publisher
SPRINGER
Is part of
Cancer Chemotherapy and Pharmacology (2016), Vol. 78, no. 1, p. 63-71
hdl
1887/99382
doi
10.1007/s00280-016-3050-6